|
× |
 |
Impact of Severity of Substance Use Disorder on Symptomatic and Functional Outcome in Young Individuals With First-Episode Psychosis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Diurnal Mood Variation in Outpatients With Major Depressive Disorder: Implications for DSM-V From an Analysis of the Sequenced Treatment Alternatives to Relieve Depression Study Data PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Obesity and Onset of Significant Depressive Symptoms: Results From a Prospective Community-Based Cohort Study of Older Men and Women PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antidepressant Medication Change in a Clinical Treatment Setting: A Comparison of the Effectiveness of Selective Serotonin Reuptake Inhibitors PDF |
$40.00 |
|
$40.00 |
|
× |
|
Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Comparison of Rates of Residual Insomnia Symptoms Following Pharmacotherapy or Cognitive-Behavioral Therapy for Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003 PDF |
$40.00 |
|
$40.00 |
|
|